In pregnant women with polycystic ovary syndrome (PCOS), metformin treatment from the late first trimester until delivery might reduce the risk for late miscarriage and preterm birth but does not prevent gestational diabetes.
Pregnant women are frequently not screened for maternal hyperlipidemia.
Docosahexaenoic acid supplements given to mothers during pregnancy may lower systolic and diastolic blood pressure associated with overweight and obesity in their children.
Gestational weight gain in excess of guidelines from the Institute of Medicine (IOM) is associated with increased risk of severe maternal morbidity.
A higher body mass index was associated with increased deiodinase activity, which in turn was associated with higher levels of glucose during pregnancy.
Detecting and addressing nocturnal hyperglycemia may help reduce rates of infants born large for gestational age in women with gestational diabetes.
Serum iodine levels appear to be associated with urinary iodine concentrations and thyroid function in pregnant women.
Higher levels of vitamin D-binding protein at the time of delivery, but not during the middle of pregnancy, were associated with a lower risk for type 1 diabetes.
Providers should maximize women’s health during the interpregnancy period, continuing care beyond the immediate postpartum period.
Postpartum women with an elevated BMI score and a history of hypertensive disorders during pregnancy have an increased risk of developing type 2 diabetes.
